Aktien Sensor

Sartorius Stedim Biotech embarks on a strategic expansion in France, bolstering its manufacturing and R&D capabilities and solidifying its position as a leader in the biotechnology sector.

Elevance Health Inc.’s stock price has fluctuated over the past few years, with recent stability despite a pending class action lawsuit alleging securities fraud.

Roche Holding AG, a pharmaceutical giant, faces scrutiny over failed trials and fatalities linked to its medications, raising concerns about its ability to navigate the risks of research and development.

IQVIA’s stock price is declining despite high demand for its services, as the company faces challenges from the Swiss healthcare system and increasing competition from innovative companies.

Bristol-Myers Squibb Co has announced a quarterly dividend payment of 62 cents per share, a move that is expected to delight investors and demonstrate the company’s commitment to returning value to its shareholders.

Shanghai Fosun Pharmaceutical Group has partnered with Teva Pharmaceutical Industries to develop a novel anti-PD1-IL2 therapy for cancer treatment.

West Pharmaceutical Services Inc is facing intense scrutiny over its volatile stock performance, with investors considering securities fraud lawsuits and questioning the company’s financial practices.

QIAGEN NV’s stock price has seen a slight increase, driven by a partnership with Incyte and optimism around its Sample to Insight solutions.

Astellas Pharma Inc is embracing innovation and collaboration through new partnerships and technologies, positioning the company for significant growth and success in the pharmaceutical industry.

Biomarin Pharmaceutical’s stock price has plummeted from $94.85 to $55, raising concerns about the company’s financial health and management decisions.